Arrhythmias, Cardiac
Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
Subtype terms (14)
More specific conditions that are subtypes of Arrhythmias, Cardiac in the MeSH hierarchy.
- Arrhythmia, Sinus
3 drugs (2 approved, 1 experimental)
- Atrial Fibrillation
223 drugs (143 approved, 80 experimental)
- Atrial Flutter
38 drugs (29 approved, 9 experimental)
- Bradycardia
24 drugs (21 approved, 3 experimental)
- Brugada Syndrome
5 drugs approved
- Cardiac Complexes, Premature
1 drug approved
- Commotio Cordis
- Heart Block
2 drugs approved
- Long QT Syndrome
15 drugs (11 approved, 4 experimental)
- Parasystole
- Pre-Excitation Syndromes
- Tachycardia
63 drugs (54 approved, 9 experimental)
- Ventricular Fibrillation
17 drugs (15 approved, 2 experimental)
- Ventricular Flutter
Drugs by status
Approved for this indication (25)
Phase 4 trials (37)
- phenylephrine
- oxytocin
- urea
- carbetocin
- cefazolin
- norepinephrine
- prednisone
- diltiazem
- empagliflozin
- insulin human
- icosapent ethyl
- iodine
- magnesium lactate
- mepivacaine
- atorvastatin
- ropivacaine
- potassium chloride
- magnesium sulfate
- epinephrine
- remimazolam
- bupivacaine
- spironolactone
- zirconium silicate
- atropine
- carvedilol
- dexmedetomidine
- fentanyl
- metoprolol
- methadone
- lansoprazole
- +7 more
Phase 3 trials (17)
Phase 2 trials (14)
Phase 1 trials (6)
Other trials (34)
- vitamin e
- astaxanthin
- beetroot juice
- dronedarone
- ethanol
- zopiclone
- ivabradine
- aluminum hydroxide
- caffeine
- proparacetamol
- pyrotinib
- red blood cells
- platelets
- rocuronium
- shensong yangxin
- sorbitol
- antihemophilic factor viii (Recombinant)
- domperidone
- midazolam
- cryoprecipitate
- oxygen
- droperidol
- hawthorn berry extract
- sodium bicarbonate
- blood plasma
- edetic acid
- loperamide
- isoprenaline
- remifentanil
- iobenguane (123i)
- +4 more
Organizations
Organization Involved with Phase 4 Indications (16)
- Harvard University
- Jordan Collaborating Cardiology Group
- University of Dundee
- University of Jordan
- University of Adelaide
- Assiut University
- University of British Columbia
- University of Connecticut
- University of Naples Frederico II
- Jordan University
- FMUSP
- University of Sao Paulo
- University of Barcelona
- Department of Veteran Affairs
- Children's National Medical Center
- Kansas City Heart Rhythm Research Foundation
Organization Involved with Phase 3 Indications (9)
Organization Involved with Phase 2 Indications (9)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (17)
- ResMed
- Hospital de Clinicas de Porto Alegre
- University of Pittsburgh
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Federal University of Rio Grande do Sul
- LHL Helse
- University of Oklahoma
- University of Bergen
- Yonsei University
- Vanderbilt University
- University of Texas at Houston
- Texas Cardiac Arrhythmia Institute
- Stiftelsen Helse og Rehabilitering
- Sungkyunkwan University
- Landsforeningen for hjerte og lungesyke (LHL)
- Oslo Metropolitan University
- Assuta Ashdod Hospital